A look at major genomic trends shaping healthcare
We are on the cusp of incredible breakthroughs in the fight against cancer. Innovations developed in research laboratories are improving treatments for patients today. By focusing on the genetic makeup of cancer cells – rather than the part of the body where someone’s cancer originated – doctors are beginning to personalize and improve
treatments for individual patients.
“For years, NFCR has been supporting molecular profiling and next-generation sequencing to better diagnose and treat cancer patients with targeted cancer therapies – and it looks like 21st century medicine will be about cancer genomics,” said Franklin Salisbury, Jr., CEO of NFCR. “As we start to move away from the old ‘location-based’ approaches of treating cancer, at NFCR we are excited that doctors everywhere are using targeted cancer therapies to better treat all types of cancer.” He adds: “21st century medicine has embraced genomic technology and the cancer field is at the forefront of these efforts to better treat cancer by looking at the genetic aspects of the disease.”
Below is an excerpt on what to expect in the field of cancer genomics from Genetic Engineering & Biotechnology News. The article is titled: “A Look Ahead: Seven Trends Shaping Genomics in 2017 and Beyond.”
Advances in Genome Sequencing, Pharmacogenomics, Gene Editing, and Biometric Wearables Will Provide New Pathways to Better Health
Genomics research holds the key to meeting many of the global healthcare challenges of the years ahead. In the last few years, costs for genetic testing have plummeted, as advances in sequencing technology have made individual genome sequencing economically feasible. Remarkable advances in genomics technologies, including pharmacogenomics, direct-to-consumer genomics, and wearable data-collection devices are leading to large pools of stored data.
Using in-memory computing technology, researchers are able to analyze and use this genomic data in innovative ways, leading to extraordinary changes in the way healthcare is delivered today. Some of these advancements are happening now, as liquid biopsy DNA tests emerge as noninvasive screening options for early cancer detection. And revolutionary gene editing techniques such as CRISPR-Cas9 may soon offer innovative ways to modify genes to treat rare genetic diseases.
A significant number of large-scale genomic projects are already underway, pointing toward positive advancements in 2017. Here’s a look at seven major trends that will shape the healthcare and life science markets in the field of genomics:
1. Integration of Genomic Data into Clinical Workflows
While major clinical centers such as Stanford Health Care and many cancer research centers are using genomic data to personalize treatments, the use of genomics in clinics nationwide is not yet commonplace. This will change in 2017… [click here to read full article]
2. On the Rise: Pharmacogenomic
Researchers have already identified a few hundred genes that are related to drug metabolism, and are continuing to identify more … [click here to read full article]
3. Emergence of Advanced Genomic Editing Techniques
This has great potential, ranging from creating a better food supply in agriculture to correcting specific mutations in the human genome … [click here to read full article]
4. Noninvasive Cancer Screening
Another key disease-fighting tool to watch in 2017 is DNA liquid biopsy testing: a cancer-screening test based on a simple blood draw … [click here to read full article]
5. More Direct-to-Consumer Genetics
Companies such as 23andMe offer direct-to-consumer testing, allowing people to explore their genetic makeup. The company provides a test that includes 65 online reports of ancestry, personal traits … [click here to read full article]
6. Growth of Newborn Genetic Screening Programs
Within the next 10 years, it is quite possible that every new baby will have their genome sequenced … [click here to read full article]
7. Integration of New Data Streams
Population health management may be where analytics bring the broadest rewards, as new data streams that include wearables data, genomics (proteomics and metabolic) data, and clinical data converge to provide a better picture of a patient’s health … [click here to read full article]
As the costs for genetic testing continue to drop and these genomic technologies advance, healthcare will transform, more cures will be discovered and the millions of people worldwide will benefit.
What is Genomic Sequencing, and Who Can Benefit?
New Research Shines Light on Rare Endometrial Cancer
Join NFCR on World Cancer Day 2022
- Cancer Awareness
- Cancer-Fighting Lifestyle
- Cancer-Fighting Food
- Cancer Prevention
- Cancer Research
- Stories that Inspire
- Szent-Györgyi Prize
Pat saysSeptember 4, 2017 at 3:05 pm
I do not see posted any info regarding genomic testing and treatment for people with stage 4 Prostate Cancer. Can you direct me to the correct place to search? My husband is currently being treated at CTCA and receives hormone replacement therapy (I think estrogen is the hormone of choice). Due to stop this therapy in November, but cancer won’t be gone. Desperate to find another treatment choice for him. Thanks.
Emergency Medicine Institute saysApril 3, 2018 at 3:48 am
Moreover, the contents are masterpiece. you’ve done a great job in this post. Thank you for this.
Denyse Bauer saysMay 26, 2019 at 12:20 am
I am trying to find out exactly what the Cancer Genomics Test CGX actually finds. Is it you actually have Cancer? or does it just mean you are genetically predisposed?
Free Cancer Screening Guidelines